<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6523">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01880203</url>
  </required_header>
  <id_info>
    <org_study_id>SWEETMAC</org_study_id>
    <nct_id>NCT01880203</nct_id>
  </id_info>
  <brief_title>Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study</brief_title>
  <acronym>SWEETMAC</acronym>
  <official_title>Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation avenir</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>laboratoire Genzyme</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the contribution of molecular cytological
      analysis (CMA) and shear wave elastography ShearWave (SWE) in the diagnosis of nodules with
      indeterminate cytology (IC)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Evaluate the diagnostic performance of the AMC and SWE elastography</measure>
    <time_frame>at inclusion, before surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the diagnostic performance of the AMC and SWE elastography in patients with a thyroid nodule CI taking as reference the histology of the nodule.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluate the diagnostic performance of elastography SWE</measure>
    <time_frame>at inclusion, before surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>For elastography SWE validate decision thresholds for the parameters of elasticity of thyroid nodules, and evaluate the diagnostic performance of elastography SWE combined with those of the standard ultrasound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Establish a combined diagnostic score results of elastography</measure>
    <time_frame>at inclusion, before surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Establish a combined diagnostic score results of elastography, the standard ultrasound and molecular analysis</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Thyroid Node</condition>
  <condition>Indeterminate Cytology</condition>
  <condition>Surgery Indication</condition>
  <arm_group>
    <arm_group_label>aspiration for Molecular Cytogenetic Analysis.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>aspiration in thyroid node for Molecular Cytogenetic Analysis.</intervention_name>
    <arm_group_label>aspiration for Molecular Cytogenetic Analysis.</arm_group_label>
    <other_name>cervical ultrasound with elastography SWE followed by a new ultrasound-guided fine needle aspiration for Molecular Cytogenetic Analysis.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Patients with thyroid nodules ≥ 15 mm with an indeterminate cytology (IC) older than
             6 months, for which a surgical indication was raised

               -  vesicular lesion of undetermined significance

               -  follicular neoplasm or Hurthle cells

               -  lesion suspicious for malignancy

          -  Confirmation of indeterminate cytology (IC) replay centralized

          -  Patient affiliated to a social security scheme

          -  Informed consent and signed

        Exclusion Criteria:

          -  Thyroid node &lt;15 mm

          -  Nodules coalescing preventing proper individualization of targeted nodule

          -  Indeterminate cytology older than six months

          -  Nodules with indeterminate cytology not, ie non-diagnostic cytology, benign and
             malignant cytology cytology

          -  Major subject to a measure of legal protection or unable to consent

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre François BACLESSE</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane BARDET, MD</last_name>
      <email>s.bardet@baclesse.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane BARDET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David BLANCHARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud CIAPUCCINI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique DE RAUCOURT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre RAME, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves REZNIK, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves REZNIK, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel BABIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé BENATEAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marjorie LOAEC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélien MEUNIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent PATRON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Américain de Paris</name>
      <address>
        <city>Neuilly sur seine</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé MONPEYSSEN, MD</last_name>
      <email>herve.monpeyssen@ahparis.org</email>
    </contact>
    <investigator>
      <last_name>Hervé MONPEYSSEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence LEENHARDHT, MD</last_name>
      <email>laurence.leenhardt@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence LEENHARDT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 14, 2013</lastchanged_date>
  <firstreceived_date>June 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thyroid</keyword>
  <keyword>elastography SWE</keyword>
  <keyword>indeterminate cytology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
